|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/30 | |||
| C07K 16/40 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2552964 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11711591.5 |
| Europos patento paraiškos padavimo data | 2011-04-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/055104 |
| Data | 2011-04-01 |
| (87) | Numeris | WO 2011/121110 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 320052 P | 2010-04-01 | US |
| (72) |
KUFER, Peter, DE
KISCHEL, Roman, DE
RAU, Doris, DE
HOFFMANN, Patrick, DE
LUTTERBUESE, Ralf, DE
KLINGER, Matthias, DE
STEIGER, Carola, DE
FLUHR, Petra, DE
HAUSMANN, Susanne, DE
MANGOLD, Susanne, DE
SCHALLER, Evelyne, DE
RAUM, Tobias, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (54) | CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |